About the Multi-Functional Cell Therapies Summit - the Future of Cell Immunotherapy
The future of cell therapies is multi-faceted. At the 2nd Multi-Functional Cell Therapies Summit, we gathered pioneers at the forefront of development to discuss the next generation of cell therapies, which boast safer, more efficacious targeting profiles.
Global innovators were able to:
Harness robust analytical strategies & manufacturing regimes to simplify the regulatory path to approval and accelerate cell therapies to clinical use with Bristol Myers Squibb, Kite Pharma & PACT Pharma
Understand the immunosuppressive barriers to conquering the TME to better inform cell therapy drug design to produce high safety & efficacy profiles with T-Knife, MD Anderson Cancer Centre & Leucid Bio
Exploit the anti-tumor properties of different cell types from NK, TILs, macrophages and more, to advise your future pipeline development with Cellectis, Carisma & Indapta
Engineer smarter delivery and targeting approaches to supercharge your therapy with maximal therapeutic impact with CERo Bio, Notch Therapeutics & 3T Biosciences
Explore the horizon of the novel innovations advancing their way to the clinic backed with the latest data to ensure your therapy is spearheading the next generation of cell therapies with AstraZeneca, Iovance & Takeda